Severe Demyelinating Neuropathy in an Advanced Melanoma Patient Treated with Nivolumab plus Ipilimumab Combined Therapy

Immune checkpoint inhibitors (ICIs) significantly prolong survival in patients with metastatic melanoma but can lead to serious immune-related adverse events. In this report, we described a case of atypical neuropathy caused by nivolumab plus ipilimumab combination therapy before primary tumor resec...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Yumi Kambayashi, Taku Fujimura, Hiroshi Kuroda, Atsushi Otsuka, Hiroyuki Irie, Setsuya Aiba
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Karger Publishers 2020-04-01
سلاسل:	Case Reports in Oncology
الموضوعات:	demyelinating peripheral neuropathy nivolumab plus ipilimumab combined therapy advanced melanoma immune-related adverse event high-dose methylprednisolone monotherapy
الوصول للمادة أونلاين:	https://www.karger.com/Article/FullText/506976
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!